TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
In: Annals of Oncology, 2023-05-01
Online
unknown
Zugriff:
Titel: |
TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
|
---|---|
Autor/in / Beteiligte Person: | Harbeck, N. ; Fasching, P.A. ; Würstlein, R. ; Degenhardt, T. ; Lüftner, D. ; Kates, R.E. ; Schumacher, J. ; Räth, P. ; Hoffmann, O. ; Lorenz, R. ; Decker, T. ; Reinisch, M. ; Göhler, T. ; Staib, P. ; Gluz, O. ; Schinköthe, T. ; Schmidt, M. |
Link: | |
Zeitschrift: | Annals of Oncology, 2023-05-01 |
Veröffentlichung: | Elsevier BV, 2023 |
Medientyp: | unknown |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2023.05.003 |
Schlagwort: |
|
Sonstiges: |
|